Cancer Discovery

Targeting RAS for Pancreatic Cancer Interception

By Sandra Misale, Neeha Zaidi, Elizabeth M. Jaffee, Alison Patricia Klein, Laura DeLong Wood

Abstract

Multiple strategies to target RAS are now available to treat pancreatic cancer. As pancreatic precancers also have KRAS mutations, these tools hold great promise for cancer interception.

The paper

Sandra Misale, Neeha Zaidi, Elizabeth M. Jaffee, Alison Patricia Klein, Laura DeLong Wood

Johns Hopkins University

Cancer Discovery, Sep 22, 2026

doi.org/10.1158/2159-8290.cd-26-1179 PubMed 42770704

Nature CommunicationsOct 17, 2026
Aged human T cells briefly regain young-like patrol behaviour
Scientific ReportsOct 17, 2026
Muscle function improved after training in older adults
European Heart Journal Cardiovascular PharmacotherapyOct 17, 2026
Dapagliflozin did not improve heart relaxation in small trial
BiomaterialsOct 17, 2026
Engineered membrane strengthens outer bone in animal models

Targeting RAS for Pancreatic Cancer Interception

Abstract

The paper

More in Interventions

Aged human T cells briefly regain young-like patrol behaviour

Muscle function improved after training in older adults

Dapagliflozin did not improve heart relaxation in small trial

Engineered membrane strengthens outer bone in animal models